MARKET

ESAIY

ESAIY

Eisai Co Ltd
OTCPK
8.21
+0.06
+0.74%
Closed 15:58 02/20 EST
OPEN
8.20
PREV CLOSE
8.15
HIGH
8.21
LOW
8.17
VOLUME
1.49K
TURNOVER
12.21K
52 WEEK HIGH
9.08
52 WEEK LOW
5.85
MARKET CAP
9.26B
P/E (TTM)
33.83
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ESAIY last week (0209-0213)?
Weekly Report · 4d ago
Eisai GAAP EPS of ¥148.31, revenue of ¥619.95B; reaffirms FY outlook
Seeking Alpha · 02/09 11:14
Weekly Report: what happened at ESAIY last week (0202-0206)?
Weekly Report · 02/09 09:38
Biogen projects 2026 revenue drop despite Q4 beat
Seeking Alpha · 02/06 12:02
Weekly Report: what happened at ESAIY last week (0126-0130)?
Weekly Report · 02/02 09:37
Medicare Targets 15 High-Profile Drugs In Third Price Negotiation Cycle
Benzinga · 01/28 10:51
Weekly Report: what happened at ESAIY last week (0119-0123)?
Weekly Report · 01/26 09:37
Reported Sunday, Eisai And Biogen Say FDA Accepts LEQEMBI IQLIK sBLA For Weekly Subcutaneous Starting Dose For Early Alzheimer's Disease, Under Priority Review, Action Date May 24, 2026
Benzinga · 01/26 07:01
More
About ESAIY
Eisai Co Ltd is a Japan-based pharmaceutical company mainly engaged in the research and development, manufacture, sale, import and export of pharmaceuticals. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Russia, Oceania), Asia and Latin America (Korea, Taiwan, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The Company is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Webull offers Eisai Co Ltd stock information, including OTCPK: ESAIY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ESAIY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ESAIY stock methods without spending real money on the virtual paper trading platform.